Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Mochida Pharmaceutical Co Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), Mochida Pharmaceutical Co Ltd tiene un total de activos de $160,121, una ganancia neta profit de $5,685

Question 2

¿Cuáles son los ratios financieros clave para MCPMF?

Accepted Answer

El ratio corriente de Mochida Pharmaceutical Co Ltd es 5.44, el margen neto es 5.4, las ventas por acción son $2,966.31.

Question 3

¿Cómo se desglosan los ingresos de Mochida Pharmaceutical Co Ltd por segmento o geografía?

Accepted Answer

Mochida Pharmaceutical Co Ltd largest revenue segment is Drug-related, at a revenue of 97,989,000,000 in the most earnings release.For geography, Japan is the primary market for Mochida Pharmaceutical Co Ltd, at a revenue of 105,159,000,000.

Question 4

¿Es rentable Mochida Pharmaceutical Co Ltd?

Accepted Answer

yes, según los últimos estados financieros, Mochida Pharmaceutical Co Ltd tiene una ganancia neta profit de $5,685

Question 5

¿Tiene Mochida Pharmaceutical Co Ltd alguna deuda?

Accepted Answer

yes, Mochida Pharmaceutical Co Ltd tiene una deuda de 29,427

Question 6

¿Cuántas acciones en circulación tiene Mochida Pharmaceutical Co Ltd?

Accepted Answer

Mochida Pharmaceutical Co Ltd tiene un total de acciones en circulación de 35.45

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	111,915	105,159	102,885	103,261	110,179	102,995
Revenue Growth (YoY)	6%	2%	0%	-6%	7%	1%
Cost of Revenue	57,717	51,371	50,815	48,146	50,626	48,203
Gross Profit	54,198	53,788	52,070	55,115	59,553	54,792
Selling, General & Admin	45,788	33,985	33,713	33,324	32,866	31,939
Research & Development	--	11,676	12,554	13,283	12,295	10,849
Operating Expenses	45,789	45,662	46,268	46,608	45,161	42,789
Other Non Operating Income (Expenses)	48	142	100	274	120	102
Pretax Income	8,770	8,052	6,160	9,044	14,591	11,900
Income Tax Expense	2,348	2,367	1,613	2,395	4,022	3,312
Net Income	6,422	5,685	4,547	6,649	10,569	8,587
Net Income Growth	13%	25%	-32%	-37%	23%	87%
Shares Outstanding (Diluted)	35.45	35.45	35.86	37.16	38.1	38.63
Shares Change (YoY)	0%	-1%	-3%	-2%	-1%	-1%
EPS (Diluted)	181.15	160.36	126.78	178.92	277.38	222.27
EPS Growth	13%	26%	-28.99%	-35%	25%	89%
Free Cash Flow	--	7,194	-9,776	5,131	4,472	7,261
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	48.42%	51.14%	50.6%	53.37%	54.05%	53.19%
Operating Margin	7.51%	7.72%	5.63%	8.23%	13.06%	11.65%
Profit Margin	5.73%	5.4%	4.41%	6.43%	9.59%	8.33%
Free Cash Flow Margin	--	6.84%	-9.5%	4.96%	4.05%	7.04%
EBITDA	--	11,066	8,610	11,179	17,081	14,745
EBITDA Margin	--	10.52%	8.36%	10.82%	15.5%	14.31%
D&A For EBITDA	--	2,940	2,808	2,672	2,689	2,742
EBIT	8,409	8,126	5,802	8,507	14,392	12,003
EBIT Margin	7.51%	7.72%	5.63%	8.23%	13.06%	11.65%
Effective Tax Rate	26.77%	29.39%	26.18%	26.48%	27.56%	27.83%

Mochida Pharmaceutical Co Ltd (MCPMF) Financial

MCPMF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is MCPMF?

MCPMF Income

Follow-Up Questions